Results 111 to 120 of about 5,155 (211)

A randomized controlled trial and prospective cohort investigating antivenom for red-bellied black snake envenomation [PDF]

open access: yes
Introduction: Antivenom is first line treatment for snake envenomation worldwide, despite few placebo controlled clinical trials demonstrating effectiveness.
Geoffrey Isbister (21130406)   +4 more
core  

Geographic mismatch between venomous snake and treatment center distributions in Brazil: a warning in the face of climate change

open access: yesPerspectives in Ecology and Conservation
Climate change is significantly altering species distributions worldwide, expanding the range of some and reducing suitable habitats for others. Concerning snakes, these changes have direct public health implications, as venomous snake species may invade
Gabriela Ferreira Campos Guerra   +2 more
doaj   +1 more source

Clinical effects and antivenom dosing in brown snake (Pseudonaja spp.) envenoming: Australian Snakebite Project (ASP-14) [PDF]

open access: yes
Background: Snakebite is a global health issue and treatment with antivenom continues to be problematic. Brown snakes (genus Pseudonaja) are the most medically important group of Australian snakes and there is controversy over the dose of brown snake ...
Bart J. Currie (7289246)   +7 more
core  

Use of immunoturbidimetry to detect venom-antivenom binding using snake venoms [PDF]

open access: yes
Introduction: Immunoturbidimetry studies the phenomenon of immunoprecipitation of antigens and antibodies in solution, where there is the formation of large, polymeric insoluble immunocomplexes that increase the turbidity of the solution.
M. A. O'Leary (21269918)   +2 more
core  

Recombinant snake antivenoms get closer to the clinic

open access: yesTrends in Immunology
Snakebite envenomings kill ~100 000 victims each year and leave many more with permanent sequelae. Antivenoms have been available for more than 125 years but are in need of innovation. A new study by Khalek et al. highlights broadly neutralizing human monoclonal antibodies (mAbs) that might be used to develop recombinant antivenoms with superior ...
openaire   +3 more sources

Purpura in serum sickness: a case of polyvalent snake antivenom reaction following Porthidium ophryomegas envenomation [PDF]

open access: yes
This reports a case of a 68-year-old woman with a history of snake bite from Porthidium ophryomegas (commonly known as Tamagás Negro), treated with polyvalent snake antivenom.
Ruiz, Jorge Raúl, Pineda, Iván Daniel
core   +1 more source

Challenges and prospects of snake antivenom supply in sub-Saharan Africa. [PDF]

open access: yesPLoS Negl Trop Dis, 2020
Habib AG   +5 more
europepmc   +1 more source

Polyspecific snake antivenom: manufacturing method development and toxicity profiling using an invertebrate model [PDF]

open access: yes
Snakebite envenoming (SBE) presents unmet challenges particularly in Sub-Saharan Africa (SSA). Almost all SBE in SSA is due to bites by snakes belonging to the Elapidae and Viperidae families. Antivenom is highly effective in treating SBE.
Mender, Mender
core  

Antivenom for neuromuscular paralysis resulting from snake envenoming [PDF]

open access: yes
Antivenom therapy is currently the standard practice for treating neuromuscular dysfunction in snake envenoming. We reviewed the clinical and experimental evidence-base for the efficacy and effectiveness of antivenom in snakebite neurotoxicity.
Wayne C. Hodgson (412268)   +2 more
core  

Home - About - Disclaimer - Privacy